Evidence map›Paper›PMID 42112239›Full record

ArticlemicroPublication biology2026

Let-7 miRNAs are Selectively Sensitive to Dicer Dosage.

Dylan Rothbort, Sharan Malagobadan, Indranil Mondal, Acong Yang, Shuo Gu

Abstract read
In one paragraph

Article in microPublication biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dylan Rothbort *RNA Biology Laboratory, National Cancer Institute, Frederick, MD, U.S.
Sharan Malagobadan *RNA Biology Laboratory, National Cancer Institute, Frederick, MD, U.S.
Indranil MondalRNA Biology Laboratory, National Cancer Institute, Frederick, MD, U.S.
Acong YangRNA Biology Laboratory, National Cancer Institute, Frederick, MD, U.S.
Shuo GuRNA Biology Laboratory, National Cancer Institute, Frederick, MD, U.S.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DICER1 syndrome is a rare cancer predisposition disorder linked to disruption of the miRNA biogenesis enzyme Dicer. To model germline DICER1 loss, we generated heterozygous knockout cell lines in mouse and human systems. While global miRNA levels were largely unaffected, the let-7 family was consistently downregulated across all models. The coordinated reduction of both guide and passenger strands, without similar effects on co-transcribed miRNAs, indicates a post-transcriptional biogenesis mechanism. These findings reveal a selective sensitivity of let-7 miRNAs to Dicer dosage and suggest a role for let-7 dysregulation in DICER1-associated tumorigenesis.

Identifiers

PMID42112239
PMCPMC13153983

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.